Login / Signup

One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.

Lei ShiYou ZhengZhi ChengNingfei JiChangming NiuYan WangTingrong HuangRuyou LiMao HuangXiaolin ChenLei ShuMingjing WuKaili DengJing WeiXueli WangYang CaoJiaxin YanGanzhu Feng
Published in: Stem cell research & therapy (2022)
Chinese Clinical Trial Registration; ChiCTR2000031494; Registered 02 April 2020-Retrospectively registered, http://www.medresman.org.
Keyphrases